USOLYE-SIBERIAN CHEMICAL AND PHARMACEUTICAL PLANT WANTS TO BE DECLARED BANKRUPT

The arbitration of the Angara region received a claim for the insolvency of the Usolsky chemical pharmaceutical plant. The initiator of the trial was the regional tax authorities. The application in the case (no. A19-27699/2022) in the amount of more than 35.6 million rubles was filed at the end of 2022.

The claim of the Federal Tax Service was accepted by the court for consideration on December 29, 2022. However, his trial, scheduled for February 6, was postponed until March 13, 2023.

The company has been operating in the region since the 1970s. Its construction began in 1966. In 1970, the plant was already producing 1,200 tons of sodium metamizole per year. To date, the organization has released over 45 million packages of 120 medicines (about 520 tons) to the market. Among the products of the plant are antibiotics, painkillers, vitamins and much more.

The production areas of the chemical pharmaceutical plant include 330 thousand square meters. meters. The company employs over 600 employees. The company is managed by Sergey Tyustin, who is the main beneficiary of the company. He owns 85% of the shares.

According to data for 2021, the plant in Usolye-Sibirsky received revenue in the amount of 1.7 billion, exceeding its 2020 figures by 45%. The plant's profit for 2021 was estimated at 144.5 million. Data for 2022 has not yet been released.

According to regional publications, bailiffs have recently initiated 143 enforcement proceedings against the chemical pharmaceutical plant. The total amount for them is over 25 million.

Photo: Freepik